
201 - 500 employees
Founded 2015
🧬 Biotechnology
💊 Pharmaceuticals
💰 $80M Post-IPO Equity - Kiniksa Pharmaceuticals on 2020-05
Biotechnology • Pharmaceuticals
Kiniksa Pharmaceuticals is a biopharmaceutical company dedicated to improving the lives of patients with debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for conditions with unmet need, with a particular focus on cardiovascular indications. Its portfolio emphasizes programs with strong biologic rationale or validated mechanisms, and the company emphasizes a patient-centered culture and rapid execution under an “Every Second Counts! ” mindset.
🕒 April 27
Regional Sales Director leading a Clinical Sales Specialists team for Kiniksa, educating healthcare providers about recurrent pericarditis and treatment. Responsible for coaching, motivating, and achieving regional sales goals.
🇺🇸 United States – Remote
💵 $250k - $270k / year
💰 $80M Post-IPO Equity - Kiniksa Pharmaceuticals on 2020-05
⏰ Full Time
🔴 Lead
🤑 Sales
🕒 April 22
Regional Clinical Sales Specialist focusing on educating healthcare providers about recurrent pericarditis treatment options. Partnering with clinical sales specialists to optimize patient experience.
🏈 Ohio – Remote
💵 $180k - $200k / year
💰 $80M Post-IPO Equity - Kiniksa Pharmaceuticals on 2020-05
⏰ Full Time
🟡 Mid-level
🟠 Senior
🤑 Sales